跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
atopic dermatitis therapy
首页
药物
atopic dermatitis therapy
atopic dermatitis therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pyrrolo[2,3-d]pyrimidine compounds
US 6956041 B2
申请人: PFIZER
优先权: 2000
US
13 件公开
US 7569569 B2
申请人: PFIZER
优先权: 2003
US
2 件公开
Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
US 8143404 B2
申请人: TAKAOKA YOSHIKAZU
优先权: 2004
CN
EP
US
8 件公开
Pyrrolo [2,3-D] pyrimidine compounds
US 6890929 B2
申请人: PFIZER
优先权: 2001
US
6 件公开
COMBINATION OF LOCAL AND SYSTEMIC THERAPIES FOR ENHANCED TREATMENT OF DERMATOLOGIC CONDITIONS
EP 3700520 C0
申请人: UNIV ROCKEFELLER
优先权: 2017
CN
EP
US
WO
5 件公开
IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT
EP 4110335 B1
申请人: VANDA PHARMACEUTICALS INC
优先权: 2020
CN
EP
US
WO
5 件公开
Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
US 2005100616 A1
申请人: MATSURA YAKUGYO CO LTD
优先权: 2002
US
4 件公开
ANTI-IL-18 ANTIBODY THERAPY FOR TREATING ATOPIC DERMATITIS
EP 4731659 A1
申请人: APOLLO AP43 LTD
优先权: 2023
CN
EP
WO
3 件公开
Dual pharmacophoresPDE4-muscarinic antagonistics
US 8067408 B2
申请人: CALLAHAN JAMES FRANCIS
优先权: 2009
CN
US
3 件公开
METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER
EP 3689364 A1
申请人: SHENZHEN EVERGREEN THERAPEUTICS CO LTD
优先权: 2010
EP
US
3 件公开
Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof
US 9233964 B2
申请人: SCHOU SØREN CHRISTIAN
优先权: 2012
CN
US
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈